Amanote Research

Amanote Research

    RegisterSign In

Commonly Setting Biological Standards in Rare Diseases

Expert Opinion on Orphan Drugs - United Kingdom
doi 10.1080/21678707.2019.1652598
Full Text
Open PDF
Abstract

Available in full text

Categories
ToxicologyPharmaceuticsPharmacologyHealth Policy
Date

August 14, 2019

Authors
Daniel J. O’ConnorJenny BucklandNeil AlmondJennifer BoyleCarmen CoxonEleni GakiJavier MartinGiada MattiuzzoClive MetcalfeMark PageNicola RoseBegona Valdazo-GonzalezYuan ZhaoChristian K. Schneider
Publisher

Informa UK Limited


Related search

Competitive Advantage Through Participation in Standards Setting?

1997English

The Economics of Setting Auditing Standards

Contemporary Accounting Research
AccountingEconomicsEconometricsFinance
2013English

Adopting Rare Diseases

Cell
BiochemistryGeneticsMolecular Biology
2015English

Setting Environmental Standards: A Statistician's Perspective

Environmental Geosciences
EarthPlanetary SciencesEnvironmental Science
2006English

Considerations in Setting Standards for Oxides of Nitrogen

Journal of the Air Pollution Control Association
1965English

Patient's Knowledge on Commonly Occurring Diseases - A Survey

Journal of Medical Science And clinical Research
2016English

Spotlight on Rare Diseases

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Developing Biological Standards for Vaccine Evaluation

Future Virology
Virology
2017English

Chemical and Biological Sensor Standards Study

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy